Prevalence of QTc Prolongation in Patients with Parkinson’s Disease. Assessment of the Effects of Drugs, Clinical Risk Factors and Used Correction Formula

Prevalence of QTc Prolongation in Patients with Parkinson’s Disease. Assessment of the Effects of Drugs, Clinical Risk Factors and Used Correction Formula

Background: Parkinson’s disease (PD) is a possible risk factor for corrected QT interval (QTc) prolongation. PD patients frequently take QTc-prolonging drugs. The aim of the study was to assess the prevalence of QTc prolongation in PD and the influence of drugs and other potential risk factors on th...

Full description

Bibliographic Details
Main Authors: Jakub J. Malkiewicz, Maciej Malkiewicz, Joanna Siuda
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Clinical Medicine
Subjects:
Parkinson’s disease
ECG
QTc prolongation
risk factors
drugs
age
Online Access:https://www.mdpi.com/2077-0383/10/7/1396

Similar Items

Similar Items